Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Regulatory Affairs / Drug Approvals News

FDA Issues Strategic Plan For Risk Communication

Main Category: Regulatory Affairs / Drug Approvals
Article Date: 01 Oct 2009 - 7:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions
Current Article Ratings:

Patient / Public:3 stars

3 (1 votes)

Health Professional:4 stars

4 (1 votes)

Article Opinions: 0 posts

The U.S. Food and Drug Administration issued its Strategic Plan for Risk Communication, which outlines the agency's efforts to disseminate more meaningful public health information. The plan also lays out a framework for the FDA to provide information about FDA-regulated products to health care professionals, patients and consumers in the form they need it and when they need it, and for how the agency oversees industry communications.

"We are committed to improving communications the public receives about the products we regulate," said Commissioner of Food and Drugs Margaret A. Hamburg, M.D. "The FDA must communicate frequently and clearly about risks and benefits and inform patients and consumers about ways to minimize risk as they become increasingly involved in managing their health and well-being."

The plan defines three key areas-FDA's science base, its operational capacity and its policy and processes - in which strategic actions can help improve the FDA's communication about the risks and benefits of regulated products. The plan also identifies over 70 specific actions for the FDA to take over the next five years, including 14 that the agency commits to accomplishing over the next year. They include:

- Designing a series of surveys to assess the public's understanding of, and satisfaction with, FDA communications about medical products
- Producing a research agenda for public dissemination
- Creating and maintaining a useful, easily accessible internal database of FDA and other relevant risk communication research
- Developing an expert model to characterize tobacco-use related consumer decision-making and better understand the likely impact of FDA oversight of tobacco products
- Developing a "library" of multi-media communications on safe food practices for general education purposes and for use with crisis communications concerning food contamination episodes
- Posting pictures of FDA- regulated products affected by Class I or high-priority Class II recalls as part of recall notices/information
- Developing detailed action plans at the agency and center levels for implementing and achieving the proposed action steps, including timelines, responsibilities and resource needs

The plan reflects the FDA's belief that risk communications must be adapted to the needs of different audiences and should be evaluated to ensure effectiveness. The plan also focuses on improving two-way communication through enhanced partnerships with government and non-government organizations, and focuses on policies that affect areas of high public health impact.

Source
U.S. Food and Drug Administration




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Haiti Appeal

Haiti Appeal Image
The severe earthquake that struck Haiti has inflicted damage and devastation on a massive scale. Please donate to the Doctors Without Borders Haiti Appeal.

PLEASE DONATE HERE


These are the most read articles from this news category for the last 6 months:
Top Article Star
FDA Approves H1N1 Vaccines, Paving Way For Large-Scale U.S. Vaccination Campaign
17 Sep 2009
HHS Secretary Kathleen Sebelius announced Tuesday during a House Energy and Commerce Committee hearing that H1N1 (swine flu) vaccines produced by four manufacturers -- CSL Ltd., Novartis, Sanofi-Pasteur and Medimmune -- had...


Coping with the Holiday Blues
Coping with the Holiday Blues

For many people, the holidays are a time of stress and sadness. Psychologist Dr. Carol Goldberg explores why and offers tips on how to avoid the holiday blues.

more videos are available in our health videos section.